5-Azacytidine
File:Azacytidine.png | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C8H12N4O5 |
Molar mass | 244.205 g/mol |
WikiDoc Resources for 5-Azacytidine |
Articles |
---|
Most recent articles on 5-Azacytidine Most cited articles on 5-Azacytidine |
Media |
Powerpoint slides on 5-Azacytidine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on 5-Azacytidine at Clinical Trials.gov Trial results on 5-Azacytidine Clinical Trials on 5-Azacytidine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on 5-Azacytidine NICE Guidance on 5-Azacytidine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on 5-Azacytidine Discussion groups on 5-Azacytidine Patient Handouts on 5-Azacytidine Directions to Hospitals Treating 5-Azacytidine Risk calculators and risk factors for 5-Azacytidine
|
Healthcare Provider Resources |
Causes & Risk Factors for 5-Azacytidine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
5-Azacytidine is a chemical analogue of cytidine, a nucleoside present in DNA and RNA. Cells in the presence of 5-azacytidine incorporate it into DNA during replication and RNA during transcription. The incorporation of 5-azacytidine into DNA or RNA inhibits methyltransferase thereby causing demethylation in that sequence, affecting the way that cell regulation proteins are able to bind to the DNA/RNA substrate. Inhibition of DNA occurs through the formation of stable complexes between the molecule and with DNA methyltransferases, thereby saturating the cells methylation machinery.
5-azacytidine and its deoxy derivative decitabine (also known as 5-aza-2'deoxycytidine) were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.[1]
It can be used in vitro to remove methyl groups from DNA. This may weaken the effects of gene silencing mechanisms that occurred prior to the methylation. Methylation events are therefore believed to secure the DNA in a silenced state. Demethylation may reduce the stability of silencing signals and thus confer relative gene activation.[2] 5-azacytidine is mainly used in the treatment of myelodysplastic syndrome. It is marketed as Vidaza.[3]
References
- ↑ Cihák A (1974). "Biological effects of 5-azacytidine in eukaryotes". Oncology. 30 (5): 405–22. PMID 4142650.
- ↑ Whitelaw E and Garrick D (2005), The Epigenome, Chapter 7, In: Mammalian Genomics, Ed: Ruvinsky A & Marshall Graves JA, CABI Publishing, Wallingford, UK, ISBN 0851999107.
- ↑ Vidaza web site.
External links
- Vidaza / Azacitidine Virtual Cancer Centre
- 5-Aza-2'-Deoxycytidine information and protocols to study DNA methylation
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Chemotherapeutic agents
- Nucleosides
- Orphan drugs